Evidence map›Paper›PMID 28348791›Full record

ArticleJMM case reports2016

Successful treatment of recurrent

Yoshihiro Fujiya, Maki Nagamatsu, Junko Tomida, Yoshiaki Kawamura, Kei Yamamoto, Momoko Mawatari, Satoshi Kutsuna, Nozomi Takeshita, Kayoko Hayakawa, Shuzo Kanagawa and 4 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in JMM case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. The first two human infections with Helicobacter zhangjianzhongii, a new Helicobacter closely related to Helicobacter canis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Dichotomous regulation of group 3 innate lymphoid cells by nongastricProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  6. Antimicrobial resistantGut pathogens · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yoshihiro FujiyaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Maki NagamatsuDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Junko TomidaDepartment of Microbiology, School of Pharmacy, Aichi Gakuin University , Aichi , Japan.
Yoshiaki KawamuraDepartment of Microbiology, School of Pharmacy, Aichi Gakuin University , Aichi , Japan.
Kei YamamotoDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Momoko MawatariDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Satoshi KutsunaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Nozomi TakeshitaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Shuzo KanagawaDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
Kazuhisa MezakiDepartment of Clinical Laboratory, National Center for Global Health and Medicine , Tokyo , Japan.
Masao HashimotoRespiratory Medicine, National Center for Global Health and Medicine , Tokyo , Japan.
Satoru IshiiRespiratory Medicine, National Center for Global Health and Medicine , Tokyo , Japan.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine , Tokyo , Japan.
National Center for Global Health and Medicine · JPAichi Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCASE PRESENTATION:

conclusionOur observations indicate that clinicians should be aware of possible recurrent

Indexed as

Helicobacter fennelliaerecurrent bacteremia, lung cancer, chemotherapyselective digestive decontamination, kanamycin

Identifiers

PMID28348791
PMCPMC5343149
OpenAlexW2550192945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.